Bionano Genomics, Inc. (BNGO) vs Dare Bioscience, Inc. (DARE)

A side-by-side comparison of Bionano Genomics, Inc. and Dare Bioscience, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BNGO vs DARE

growth of $100 · dividends reinvested · last 8y
BNGO -100.0% (-62.5%/yr)DARE -92.9% (-28.2%/yr)DARE compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $1002020202220242026$0$7
BNGO DARE

BNGO vs DARE: by the numbers

  • •BNGO is the larger company ($17M vs $13M market cap).
  • •Both run net losses; BNGO's is the smaller (-106.58% vs -804.37% net margin).

Metrics side by side

Valuation

MetricBNGODARE
P/S ratio0.559.25
P/B ratio0.52N/A

Profitability

MetricBNGODARE
Gross margin21.95%-137.55%
Operating margin-116.95%-1315.51%
Net margin-106.58%-804.37%
ROE-101.76%N/A
ROIC-85.72%-203.50%

Growth (annualized)

MetricBNGODARE
Revenue CAGR (5Y)17.97%N/A
Total return CAGR (5Y)-78.37%-46.35%

Frequently asked

How have BNGO and DARE total returns compared?
Over the past 5 years, BNGO delivered -78.37% and DARE delivered -46.35% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.